US 2006/0069115 A1Published application

Use of pde4 inhibitors as adjunct therapy for psychiatric disorders

OwnerEdward Scolnickinventor

Life of this patent

Estimating the term…

Abstract

The use of a PDE4 inhibitor in conjunction with psychotherapy provides enhanced therapeutic results in the treatment of psychiatric disorders including, for example, specific phobias, panic disorders, anxiety disorders including posttraumatic stress disorders, and obsessive-compulsive disorder.

Claims12

Dependent claims

A method for the treatment of psychiatric disorder in a patient, said method comprises administering to said patient a therapeutically effective amount of a PDE4 inhibitor in combination with psychotherapy.

Dependencies are inferred from the claim text.

Facts

Application: 10/530,841Filed 10 Nov 2003
Priority: 15 Nov 2002
Published: 30 Mar 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 31/42
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: oxazoles
A61K 31/425
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thiazoles

Family

Application60/426,529Us provisional application · filed 15 Nov 2002
US 2006/0069115 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results